Showing results (11-20 of 719) with videos related to

Sort By:
Pageof 72
Plos One|January 26, 2018
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patientsMiquel Ferrer, Chiara Travierso, Catia Cilloniz, et al.
Critical Care (London, England)|September 15, 2011
Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosisCatia Cillóniz, Santiago Ewig, Miquel Ferrer, et al.
The European Respiratory Journal|January 24, 2015
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosisAntoni Torres, Catia Cillóniz, Miquel Ferrer, et al.
Respiratory Research|October 2, 2017
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up studyRosario Menéndez, Raúl Méndez, Eva Polverino, et al.
Respirology (Carlton, Vic.)|June 10, 2014
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical studyMiquel Ferrer, Antoni Torres, Raquel Martínez, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2013
Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumoniaJacobo Sellares, Alejandra López-Giraldo, Carmen Lucena, et al.
Chest|December 24, 2011
Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumoniaRosario Menéndez, José Miguel Sahuquillo-Arce, Soledad Reyes, et al.
The Journal of Infection|May 1, 2012
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumoniaCatia Cillóniz, Santiago Ewig, Rosario Menéndez, et al.
Respirology (Carlton, Vic.)|November 9, 2012
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcomeEva Polverino, Catia Cillóniz, Povilas Dambrava, et al.
Pageof 72